HOME >> BIOLOGY >> NEWS
American Heart Association Announces Top 10 Research Advances For 1998 -- Gene Therapy Among The List

ood flow in the blood vessel. Those who received the platelet blockers had a 30 percent reduced risk of all-cause death than those who did not receive the drugs. The individuals who particularly benefited from the drugs were those who also were treated with angioplasty. In these individuals the drug was administered just as the coronary arteries were being opened by inflation of the balloon-tipped catheters used for the procedure. Studies are now underway to test the combination of platelet blockers and clot-dissolving medicines in heart attack patients.

3. Inflammation and heart attacks
The American Heart Association recommends that people at high risk for heart attack and stroke take aspirin because research studies have shown that this low-cost, over-the- counter drug helps prevent the blood clots that can trigger heart attacks and strokes. Aspirin, however, may have another benefit for people at high risk for heart attacks and stroke. Aspirin is an anti-inflammatory drug, and recent research suggests that the body's inflammatory response to an unnatural condition in the body -- a virus or other microbe, high blood cholesterol levels, or cigarette smoking --may play a role in cardiovascular disease. In recent years scientists were intrigued by research showing that the area of the blood vessel where a plaque obstruction develops can become inflamed and that the inflammation can actually weaken the surface of the plaque obstruction, making it more prone to rupture which can cause a dangerous blood clot. "This year, the 'news' is that the inflammatory response is not only localized in the blood vessel wall," Fuster says. "It also can occur not only throughout the bloodstream." Systemic inflammation may explain the development of blood clots on top of relatively stable plaque obstructions, thereby causing the occlusions in the coronary arteries that trigger heart attacks, says Fuster. "The critical issue here is that blood components that are
'"/>

Contact: Cathy Yarbrough
cathyy@heart.org
214-706-1340
American Heart Association
30-Dec-1998


Page: 1 2 3 4 5 6 7 8 9 10

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:
(Date:3/12/2015)... 12, 2015 IriTech, a leading iris based ... the Texas Instruments Design Network, announced today that the ... its IriShield USB MK2120U device during a launching event ... distribution. The iris scanner is manufactured ... in India through its Indian ...
(Date:3/12/2015)... March 12, 2015 Beta ... identity and access management (IAM) solution for a ... With Beta System,s new IAM package, customers benefit ... gleaned from multiple IAM implementations across different industries. ... as well as any necessary services and consulting. ...
(Date:3/11/2015)... , Mar. 11, 2015 Research and Markets ... of the "Access Control Market by Product, Application ... 2020" report to their offering. , ... expected to reach $10.4 billion by 2020, with an ... market report covers the products types such as contact ...
Breaking Biology News(10 mins):Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2
(Date:3/31/2015)... Materials in Society Lecture Series at   ...   Elsevier , a world-leading provider of ... home of Materials Today , announced that its ... in Society  Lecture Series . The inaugural lectures ... Conference on Materials for Advanced Technologies (ICMAT) to be ...
(Date:3/31/2015)... March 31, 2015  Sonoa Health, a health tech ... has developed a world-first consumer health portal, Health&, which ... wearable devices and more. Today, the Company ... its CEO, who brings to the table more than ... has included working closely with the biggest names in ...
(Date:3/31/2015)... , March 31, 2015   Mapi ... integrating Mapi,s Medical Affairs and global Risk Management ... a previously announced acquisition . ... are conducted by a global team that includes ... have decades of experience in navigating complex safety ...
(Date:3/31/2015)... NEW YORK , March 31, ... ), a biopharmaceutical company advancing protein biologic therapies ... its Korean marketing partner, Hanmi Pharmaceutical Co., Ltd ... Korea from the country,s Ministry of Food and ... Research Institute (KTR) for MuGard, its oncology supportive-care ...
Breaking Biology Technology:Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 2Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 3Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3
Cached News: